Share ownership Mesa Laboratories, Inc.

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-09-02 EDT			5-day change	1st Jan Change
130.65 ^USD	+4.13%		+2.59%	+66.43%

08-10	Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026
08-10	Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005.	CI

Share class: Mesa Laboratories, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,595,869	5,281,396 ( 94.38 %)	0	94.38 %

Major shareholders: Mesa Laboratories, Inc.

Name	Stocks	%	Valuation
Long Path Partners LP 8.526 %	477,126	8.526 %	48 M $
BlackRock Advisors LLC 7.264 %	406,485	7.264 %	41 M $
Vanguard Fiduciary Trust Co. 5.795 %	324,299	5.795 %	33 M $
Boston Partners Global Investors, Inc. 4.738 %	265,149	4.738 %	27 M $
Vanguard Capital Management LLC 4.243 %	237,457	4.243 %	24 M $
AQR Capital Management LLC 3.641 %	203,739	3.641 %	21 M $
Ranger Investment Management LP 3.109 %	173,988	3.109 %	18 M $
Eaton Vance Management 2.805 %	156,979	2.805 %	16 M $
Diamond Hill Capital Management LLC 2.784 %	155,771	2.784 %	16 M $
Eagle Asset Management, Inc. 2.679 %	149,937	2.679 %	15 M $
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	84.22%
Others	8.7%
Individuals	4.24%
State Street Corp.	2.22%
SEI Investments Co.	0.12%
Unknown	0.5%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	88.73%
Individuals	4.24%
Australia	2.48%
United Kingdom	2.14%
France	0.67%
Ireland	0.52%
Cayman Islands	0.31%
Hong Kong	0.18%
Canada	0.17%
Singapore	0.05%
Luxembourg	0.01%

Based on 1000 largest holdings

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Employees

717

Sector

Medical Equipment, Supplies & Distribution

More about the company